Outset Medical Inc header image

Outset Medical Inc

OM

Equity

ISIN null / Valor 56717137

NASDAQ (2026-10-06)
USD 4.14+0.98%

Outset Medical Inc
UMushroom community rating:

star star star star star
3.80 5 votes No rating yet
NegativeNeutralPositive

About company

Outset Medical Inc. is a healthcare company that specializes in innovative solutions for the nephrology market, focusing on improving the care model for acute renal failure both in intensive and sub-acute hospital settings. The company is known for its commitment to applying industrial continuous quality improvement concepts to nephrology, aiming to transform patient care through technology and innovation. Outset Medical's approach includes the development of medical devices and services that cater to the specific needs of patients and healthcare providers in the field of dialysis. With a team that includes experts like Dr. Alvarez, who serves as the Chief Technology and Innovation Advisor and brings a wealth of experience from both clinical practice and the pharmaceutical and device industries, Outset Medical positions itself at the forefront of nephrology care. The company offers differentiated service agreements tailored to meet the unique needs and capabilities of each customer, indicating a flexible and patient-centric approach to healthcare solutions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-72.2%1Y
-97.2%3Y
-99.4%5Y

Performance

111%1Y
132%3Y
113%5Y

Volatility

Market cap

78 M

Market cap (USD)

Daily traded volume (Shares)

376,616

Daily traded volume (Shares)

1 day high/low

1.21 / 1.09

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.80

5 votes
Performance:
starstarstarstarstar
3.50
Innovation:
starstarstarstarstar
4.25
Society:
starstarstarstarstar
4.50
Nature:
starstarstarstarstar
3.50
Melanie S
Switzerland, 30 Mar 2025
star star star star star
noch nie von gehört, klingt aber spannend
Caterina F
Switzerland, 28 Mar 2025
star star star star star
Interesting
Mahmut Yasar
Switzerland, 28 Mar 2025
star star star star star
Super Anlage

EQUITIES OF THE SAME SECTOR

IQVIA Holdings Inc
IQVIA Holdings Inc IQVIA Holdings Inc Valor: 39103858
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.30%USD 259.98
Arvinas Inc
Arvinas Inc Arvinas Inc Valor: 43526042
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.01%USD 7.31
AstraZeneca PLC
AstraZeneca PLC AstraZeneca PLC Valor: 982352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.65%GBP 119.58
Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1103058
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.70%GBP 10.12
Envista Holdings Corporation
Envista Holdings Corporation Envista Holdings Corporation Valor: 49153522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.30%USD 23.27
Humana Inc
Humana Inc Humana Inc Valor: 940174
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.05%USD 404.27
Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC Valor: 2324471
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.60%GBP 16.20
Indivior PLC
Indivior PLC Indivior PLC Valor: 121550831
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.67%GBP 27.04
Beximco Pharmaceuticals Ltd
Beximco Pharmaceuticals Ltd Beximco Pharmaceuticals Ltd Valor: 2318407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%GBP 0.54
Pharma Mar SA
Pharma Mar SA Pharma Mar SA Valor: 56130572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.93%EUR 70.30